U

University General Hospital of Heraklion | Clinic of Rheumatology - Clinical Immunology

Research site
(Unclaimed)
Location
Stavrakia Voutes, Heraklion, Crete, Greece

Site insights

Top conditions

Top treatments

LY2835219
Abemaciclib
Fulvestrant

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

2 of 2 total trials

A Study of Abemaciclib (LY2835219) Combined With Fulvestrant in Women With Hormone Receptor Positive HER2 Negative Breast Cancer (MONARCH 2)

The main purpose of this study is to compare progression-free survival for women with hormone receptor positive (HR+), human epidermal growth factor...

Active, not recruiting
Breast Neoplasms
Drug: Placebo
Drug: Fulvestrant

The purpose of this study is to evaluate the safety and efficacy of the study drug abemaciclib in participants with high risk, node positive, early s...

Active, not recruiting
Breast Cancer
Drug: Standard Adjuvant Endocrine Therapy
Drug: Abemaciclib

Trial sponsors

Lilly logo

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems